Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neurogene (NGNE) Operating Leases: 2019-2025

Historic Operating Leases for Neurogene (NGNE) over the last 5 years, with Sep 2025 value amounting to $7.1 million.

  • Neurogene's Operating Leases fell 45.52% to $7.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $7.1 million, marking a year-over-year decrease of 45.52%. This contributed to the annual value of $9.4 million for FY2024, which is 36.73% down from last year.
  • As of Q3 2025, Neurogene's Operating Leases stood at $7.1 million, which was down 9.28% from $7.8 million recorded in Q2 2025.
  • Neurogene's Operating Leases' 5-year high stood at $14.9 million during Q4 2023, with a 5-year trough of $7.1 million in Q3 2025.
  • For the 3-year period, Neurogene's Operating Leases averaged around $10.7 million, with its median value being $9.5 million (2023).
  • As far as peak fluctuations go, Neurogene's Operating Leases skyrocketed by 43.98% in 2024, and later slumped by 45.52% in 2025.
  • Neurogene's Operating Leases (Quarterly) stood at $14.9 million in 2023, then crashed by 36.73% to $9.4 million in 2024, then tumbled by 45.52% to $7.1 million in 2025.
  • Its Operating Leases was $7.1 million in Q3 2025, compared to $7.8 million in Q2 2025 and $8.6 million in Q1 2025.